In Retrospect Martin Shkreli Can See Now That Maybe He Should Actually Have Charged More
On Thursday, at the Forbes Healthcare Summit in Manhattan, Martin Shkreli said that, given the chance, not only would he raise the price of Daraprim, a drug of particular usefulness to AIDS and cancer patients, to $750 per tablet from $13.50 again, but he’d go even higher.